Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-02

Clinical Trial Update: A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluated a DPP-IV inhibitor in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DPP-IV inhibitor

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED